Cancer Genet Cytogenet 2008, 185: 20–27.CrossRefPubMed 13. Assumpção JG, Seidinger AL,

Mastellaro MJ, Ribeiro RC, Zambetti GP, Ganti R, Srivastava K, Shurtleff S, Pei D, Zeferino LC, Dufloth RM, Brandalise SR, Yunes JA: Association of the germline TP53 R337H mutation with breast cancer in southern Brazil. BMC Cancer 2008, 8: 357.CrossRefPubMed 14. Mahdavinia M, Bishehsari F, check details Verginelli F, Cumashi A, Lattanzio R, Sotoudeh M, Ansari R, Semeraro D, Hormazdi M, Fakheri H, Rakhshani N, De Lellis L, Curia MC, Cama A, Piantelli M, Malekzadeh R, Iacobelli S, Mariani-Costantini R: P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor ��-Nicotinamide origin, microsatellite instability and K-ras mutations. J Cell Physiol 2008, S3I-201 supplier 216: 543–550.CrossRefPubMed 15. Ara S, Lee PS, Hansen MF, Saya H: Codon 72 polymorphism of the TP53 gene. Nucleic Acids Res 1990, 18: 4961.CrossRefPubMed 16. Shen H, Solari A, Wang X, Zhang Z, Xu

Y, Wang L, Hu X, Guo J, Wei Q: P53 codon 72 polymorphism and risk of gastric cancer in a Chinese population. Oncol Rep 2004, 11: 1115–1120.PubMed 17. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L: Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 1998, 393: 229–234.CrossRefPubMed 18. Wang YC, Lee HS, Chen SK, Chang YY, Chen CY: Prognostic significance of p53 codon 72 polymorphism in lung carcinomas. Eur J Cancer 1999, 35: 226–230.CrossRefPubMed 19. Yu MW, Yang SY, Chiu YH, Chiang YC, Liaw YF, Chen CJ: A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B

carriers. Hepatology 1999, 29: 697–702.CrossRefPubMed 20. Mabrouk I, Baccouche S, El-Abed R, Mokdad-Gargouri R, Mosbah A, Saïd S, Daoud J, Frikha M, Jlidi R, Gargouri A: No evidence of correlation between p53 codon 72 polymorphism and risk of bladder or breast carcinoma in Tunisian patients. Ann N Y Acad Sci 2003, 1010: 764–770.CrossRefPubMed 21. Zhou Y, Li N, Zhuang W, Liu GJ, Wu TX, Yao X, Du L, Wei ML, Wu XT: P53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literature. Int J Cancer 2007, 121: 1481–1486.CrossRefPubMed 22. Khayat AS, Lobo Gatti L, Moura Lima E, de Assumpção PP, Protein Tyrosine Kinase inhibitor Nascimento Motta FJ, Harada ML, Casartelli C, Marques Payão SL, Cardoso Smith MA, Burbano RR: Polymorphisms of the TP53 codon 72 and WRN codon 1367 in individuals from Northern Brazil with gastric adenocarcinoma. Clin Exp Med 2005, 5: 161–168.CrossRefPubMed 23. Munafò MR, Clark TG, Flint J: Assessing publication bias in genetic association studies: evidence from a recent meta-analysis. Psychiatry Res 2004, 129: 39–44.CrossRefPubMed 24. Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315: 629–634.PubMed 25.